ERBB2 and neoplasm: Moreover, the cell-killing effect at an E:T ratio of 5:1 was greater than that at an E:T ratio of 2.5:1 (Fig. 3A), indicating that HER2-CAR-T cells had a dose-dependent effect on tumor cell killing.